New Diabetes Treatment Approved: Jardiance

Roni Shye
Roni Shye, PharmD BCGP BCACP, is a licensed pharmacist in the states of Florida, Ohio, and Pennsylvania.
Posted on

Jardiance (empagliflozin) was approved by the FDA on August 1, 2014 for the treatment of type 2 diabetes.

What type of medication is Jardiance?
Jardiance is part of a new class of medications recently approved by the FDA, Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors.

How does Jardiance work?

It works with the body’s natural process of urination to help remove more excess sugar from the body rather than allowing it to be reabsorbed by your kidneys.

How is this medication usually taken?

It’s recommended that you take Jardiance once daily in the morning with or without food. Jardiance is also to be used with a healthy diet and exercise.

It will be available in 10 mg & 25 mg tablets.

For more information, check out the package insert and prescribing information here.

What are the common side effects?

Common side effects include female genital infections & urinary tract infections.

What are the benefits of Jardiance?

Not only has this medication been shown to lower blood glucose levels but it can also help with weight loss, a reduction of A1C levels, and in lowering blood pressure–all of which can be concerns for diabetics.

Who should NOT take this medication?
Jardiance is not for Type 1 diabetics or people with diabetic ketoacidosis.

Are there any similar medications available?

Yes. There are two other medications in the same class, Invokana and Farxiga, which have recently been approved.

Invokana was approved on March 29, 2013 and the newest medication, Farxiga, was approved on January 8, 2014.

Want to learn more information about Jardiance? Check out this article!

Drugs featured in this story

Filed under